BNET Industries

Warnex Inc.

WNX is in the Pharma Industry

Last Fiscal Year Sales:$14.9M
  • Public
  • CA
Dow Jones Description

Biotechnology Services

Number of Employees 200
Contact Information

3885 Industriel Blvd

Laval, Quebec

www.warnex.ca

(450) 663-6724

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Bay Street Stocks Move Modestly Higher As Gold Holds Record Levels

    11/14/09 - Financial Announcement - View Story

  • Warnex Launches Test for Influenza a H1N1 Virus Mutation Associated With Resistance to TamifluR

    8/27/09 - Product Announcement - View Story

  • Warnex loses $346,660 in Q2 2009

    8/11/09 - Financial Announcement - View Story

  • Warnex and Rosetta Genomics Announce Exclusive Distribution Agreement for Rosetta's microRNA-Based Assays in Canada

    8/10/09 - Joint Venture / Alliance - View Story

  • Thunder Bay DNA lab involved in Amelia Earhart investigation Posted: 7/31/2009 9:07:54 AM

    8/05/09 - Merger / Acquisition - View Story

  • Warnex acquires Molecular World

    6/12/09 - Merger / Acquisition - View Story

News & Analysis

warnex inc. - All News and Analysis

  • Warnex Concludes Acquisition of Molecular World Inc.

    - 2009-06-12

    Warnex Inc. (TSX: WNX) announced today that it has concluded the acquisition of all of the issued and outstanding shares of Molecular World Inc., a laboratory located in Thunder Bay, Ontario, specialized in human DNA identification including forensic DNA testing, following an agreement in principle announced on May...

    Tags: Warnex Inc.

  • Warnex Concludes Acquisition of Molecular World Inc.

    - 2009-06-12

    LAVAL, QUEBEC, Jun 12, 2009 Marketwire via COMTEX -- Warnex Inc. (TSX:WNX) announced today that it has concluded the acquisition of all of the issued and outstanding shares of Molecular World Inc., a laboratory located in Thunder Bay, Ontario, specialized in human DNA identification...

    Tags: Warnex Inc.

  • Warnex Launches Test for Influenza A H1N1 Virus

    - 2009-06-02

    Warnex Inc. (TSX: WNX) announced today that its Medical Laboratories division has launched a test for the detection of the influenza A H1N1 virus. The test, based on Real-Time Polymerase Chain Reaction (RT-PCR) technology specifically detects all influenza A viruses and then presumptively identifies the A H1N1 strain....

    Tags: Warnex Inc.

  • Warnex Launches Test for Influenza A H1N1 Virus.

    - 2009-06-02

    LAVAL, QUEBEC, Jun 2, 2009 Marketwire via COMTEX -- Warnex Inc. (TSX:WNX) announced today that its Medical Laboratories division has launched a test for the detection of the influenza A H1N1 virus. The test, based on Real-Time Polymerase Chain Reaction (RT-PCR) technology specifically detects...

    Tags: Warnex Inc.

  • Warnex Enters Into Agreement in Principle for the Acquisition of Molecular World Inc.

    - 2009-05-27

    Warnex Inc. (TSX: WNX) announced today that it has entered into an agreement in principle for the acquisition of Molecular World Inc., a laboratory located in Thunder Bay, Ontario, specialized in human DNA identification including forensic DNA testing. The purchase price will be paid by the issuance of...

    Tags: Warnex Inc.